This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Teva Pharmaceuticals International Gmbh. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Inbal Shumacher: Innovator in Pharmaceutical Chemistry
Introduction
Inbal Shumacher is a notable inventor based in Kadima, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid-state forms of medications. With a total of 2 patents, his work has the potential to impact the pharmaceutical industry positively.
Latest Patents
Inbal Shumacher's latest patents focus on solid-state forms of Belumosudil and its salts. The present disclosure encompasses solid-state forms of Belumosudil, including crystalline polymorphs of Belumosudil or salts thereof. It also details processes for the preparation of these forms and their pharmaceutical compositions. This innovation is crucial for enhancing the efficacy and stability of the medication.
Career Highlights
Throughout his career, Inbal has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Teva Pharmaceuticals International GmbH and Assia Chemical Industries Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Inbal has collaborated with several professionals in his field, including Polina Lapido and Ofir Shaul. These collaborations have likely enriched his research and development efforts, fostering a creative environment for innovation.
Conclusion
Inbal Shumacher stands out as an inventor dedicated to advancing pharmaceutical chemistry through his innovative patents. His work on solid-state forms of Belumosudil showcases his commitment to improving medication formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
